Prostatic Artery Embolization Is Safe and Effective for Medically Recalcitrant Radiation-Induced Prostatitis.


Journal

Advances in radiation oncology
ISSN: 2452-1094
Titre abrégé: Adv Radiat Oncol
Pays: United States
ID NLM: 101677247

Informations de publication

Date de publication:
Historique:
received: 06 03 2020
accepted: 12 03 2020
entrez: 21 10 2020
pubmed: 22 10 2020
medline: 22 10 2020
Statut: epublish

Résumé

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) represents 90% of all chronic prostatitis cases and may occur after radiation therapy (RT) for localized prostate cancer. Medical therapy is effective in approximately 50% of cases, with no therapy demonstrating consistent efficacy in refractory cases. Prostatic artery embolization (PAE) is effective in men with lower urinary tract symptoms and benign prostatic hyperplasia. We report clinical improvement after PAE in a case series of men with CP/CPPS after RT. Nine men (median age 72 years; range, 61-83 years) with CP/CPPS after RT for prostate cancer underwent PAE. Baseline International Prostate Symptom Score was recorded in 5 patients (median 23; range, 4-26), Chronic Prostatitis Symptom Index score in 6 patients (median 22.5; range, 6-34), and quality of life (QoL) score in 8 patients (median 5; range, 2-6). Median baseline prostate volume was 49 cm Technical success (ie, bilateral embolization) was achieved in 78% (n = 7) of patients with the other 2 patients having undergone unilateral embolization with no major complications. Clinical success was seen in 89% (n = 8) of patients and QoL improved in 78% (n = 7) during the follow-up period. CP/CPPS after RT for localized prostate cancer is a highly morbid condition, with medical therapy successful in only 50% of cases. PAE may be a successful therapy for medically recalcitrant CP/CPPS, and further studies are necessary to understand the best patient selection and scenario for PAE in the setting of CP/CPPS.

Identifiants

pubmed: 33083652
doi: 10.1016/j.adro.2020.03.015
pii: S2452-1094(20)30068-3
pmc: PMC7557125
doi:

Types de publication

Journal Article

Langues

eng

Pagination

905-909

Informations de copyright

© 2020 The Author(s).

Références

JAMA. 2011 Jan 5;305(1):78-86
pubmed: 21205969
J Vasc Interv Radiol. 2018 May;29(5):589-597
pubmed: 29580712
Cardiovasc Intervent Radiol. 2019 Oct;42(10):1405-1412
pubmed: 31062066
Can Urol Assoc J. 2011 Oct;5(5):306-15
pubmed: 22031609
PLoS One. 2012;7(8):e41941
pubmed: 22870266
J Vasc Interv Radiol. 2014 Jan;25(1):47-52
pubmed: 24176946
Indian J Urol. 2016 Jan-Mar;32(1):34-9
pubmed: 26941492
Pract Radiat Oncol. 2014 Jan-Feb;4(1):27-34
pubmed: 24621420
Cardiovasc Intervent Radiol. 2013 Apr;36(2):403-11
pubmed: 23232858
JAMA. 1999 Jul 21;282(3):236-7
pubmed: 10422990
Urology. 1993 Apr;41(4):301-7
pubmed: 8470312
BJU Int. 2012 Oct;110(7):1014-22
pubmed: 22471591
Can J Urol. 2012 Aug;19(4):6373-80
pubmed: 22892261
Am Fam Physician. 2016 Feb 15;93(4):290-6
pubmed: 26926816
J Vasc Interv Radiol. 2017 Oct;28(10):1432-1437.e3
pubmed: 28757285
Radiology. 2014 Mar;270(3):920-8
pubmed: 24475799

Auteurs

Nainesh Parikh (N)

Department of Diagnostic Imaging and Interventional Radiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.

Edward Keshishian (E)

Department of Diagnostic Imaging and Interventional Radiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.

Ayushman Sharma (A)

Department of Diagnostic Imaging and Interventional Radiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.

Monica Roca (M)

Department of Diagnostic Imaging and Interventional Radiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.

Brandon Manley (B)

Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.

Michael Poch (M)

Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.

G Daniel Grass (GD)

Department of Radiation Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.

Javier Torres-Roca (J)

Department of Radiation Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.

David Boulware (D)

Department of Biostatistics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.

Peter Johnstone (P)

Department of Radiation Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.

Michael Montejo (M)

Department of Radiation Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.

Johnna Smith (J)

Department of Diagnostic Imaging and Interventional Radiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.

Julio Pow-Sang (J)

Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.

Kosj Yamoah (K)

Department of Radiation Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.

Classifications MeSH